Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-02-20 @ 6:03 PM
Study NCT ID:
NCT04681820
Status:
UNKNOWN
Last Update Posted:
2023-08-01
First Post:
2020-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HS-2020-07WH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None